A 62-year-old man with type 2 diabetes, hypertension and dyslipidaemia is reviewed in clinic. His LDL-C is 3.1 mmol/L, HDL-C 0.9 mmol/L and triglycerides 2.0 mmol/L. His 10-year atherosclerotic cardiovascular disease risk is 24%. He has no history of myocardial infarction or stroke. According to the 2021 Canadian Cardiovascular Society dyslipidaemia guideline, what is the most appropriate lipid-lowering strategy?